- Home
- IVVD vs LXEH Comparison
IVVD vs LXEH Comparison
Compare IVVD & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- LXEH
- Stock Information
- Founded
- IVVD 2020
- LXEH 2001
- Country
- IVVD United States
- LXEH China
- Employees
- IVVD N/A
- LXEH N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- LXEH Other Consumer Services
- Sector
- IVVD Health Care
- LXEH Real Estate
- Exchange
- IVVD Nasdaq
- LXEH Nasdaq
- Market Cap
- IVVD 63.4M
- LXEH 55.2M
- IPO Year
- IVVD 2021
- LXEH 2020
- Fundamental
- Price
- IVVD $1.43
- LXEH $2.39
- Analyst Decision
- IVVD Strong Buy
- LXEH
- Analyst Count
- IVVD 4
- LXEH 0
- Target Price
- IVVD $3.64
- LXEH N/A
- AVG Volume (30 Days)
- IVVD 15.0M
- LXEH 3.9M
- Earning Date
- IVVD 11-13-2025
- LXEH 09-26-2025
- Dividend Yield
- IVVD N/A
- LXEH N/A
- EPS Growth
- IVVD N/A
- LXEH N/A
- EPS
- IVVD N/A
- LXEH N/A
- Revenue
- IVVD $46,210,000.00
- LXEH $4,493,795.00
- Revenue This Year
- IVVD $385.94
- LXEH N/A
- Revenue Next Year
- IVVD $62.62
- LXEH N/A
- P/E Ratio
- IVVD N/A
- LXEH N/A
- Revenue Growth
- IVVD 1941.08
- LXEH N/A
- 52 Week Low
- IVVD $0.35
- LXEH $1.12
- 52 Week High
- IVVD $2.74
- LXEH $50.08
- Technical
- Relative Strength Index (RSI)
- IVVD 72.86
- LXEH 65.46
- Support Level
- IVVD $0.96
- LXEH $1.72
- Resistance Level
- IVVD $1.45
- LXEH $2.34
- Average True Range (ATR)
- IVVD 0.19
- LXEH 0.21
- MACD
- IVVD 0.05
- LXEH 0.06
- Stochastic Oscillator
- IVVD 97.86
- LXEH 93.58
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.